Pravin Dugel - Apr 28, 2025 Form 4 Insider Report for OCULAR THERAPEUTIX, INC (OCUL)

Role
Executive Chairman, President and CEO, Director
Signature
/s/ Todd Anderman, Attorney-in-Fact for Pravin Dugel
Stock symbol
OCUL
Transactions as of
Apr 28, 2025
Transactions value $
$0
Form type
4
Date filed
8/13/2025, 07:02 PM
Previous filing
Feb 26, 2025
Next filing
May 27, 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Dugel Pravin Executive Chairman, President and CEO, Director C/O OCULAR THERAPEUTIX, INC., 15 CROSBY DRIVE, BEDFORD /s/ Todd Anderman, Attorney-in-Fact for Pravin Dugel 2025-08-13 0001700917

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction OCUL Common Stock Gift $0 -200K -5.73% $0.00 3.3M Apr 28, 2025 Direct F1
transaction OCUL Common Stock Gift $0 -50K -1.52% $0.00 3.25M Jun 12, 2025 Direct F2
transaction OCUL Common Stock Gift $0 +250K $0.00 250K Aug 11, 2025 By Pravin Dugel 2024 Irrevocable Trust F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On April 28, 2025, the reporting person transferred 200,332 shares to his spouse for no consideration.
F2 On June 12, 2025, the reporting person transferred 50,029 shares to his spouse for no consideration.
F3 On August 11, 2025, the reporting person's spouse transferred 250,361 shares to the Pravin Dugel 2024 Irrevocable Trust (the "Trust") for no consideration. The reporting person is trustee of the Trust and sole beneficiary of the Trust during his lifetime. The reporting person remains the beneficial owner of the securities held by the Trust.

Remarks:

Executive Chairman, President and CEO